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Abstract
CvaB is the central membrane transporter of the colicin V secretion system that belongs to an ATP-binding cassette
superfamily. Previous data showed that the N-terminal and C-terminal domains of CvaB are essential for the function of
CvaB. N-terminal domain of CvaB possesses Ca
2+-dependent cysteine proteolytic activity, and two critical residues, Cys32
and His105, have been identified. In this study, we also identify Asp121 as being the third residue of the putative catalytic
triad within the active site of the enzyme. The Asp121 mutants lose both their colicin V secretion activity and N-terminal
proteolytic activity. The adjacent residue Pro122 also appears to play a critical role in the colicin V secretion. However, the
reversal of the two residues D121P - P122D results in loss of activity. Based on molecular modeling and protein sequence
alignment, several residues adjacent to the critical residues, Cys32 and His105, were also examined and characterized. Site-
directed mutagenesis of Trp101, Asp102, Val108, Leu76, Gly77, and Gln26 indicate that the neighboring residues around the
catalytic triad affect colicin V secretion. Several mutated CvaB proteins with defective secretion were also tested, including
Asp121 and Pro122, and were found to be structurally stable. These results indicate that the residues surrounding the
identified catalytic triad are functionally involved in the secretion of biologically active colicin V.
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Introduction
CvaB is the central membrane transporter of the bacteriocin
colicin V secretion system in Escherichia coli. It has been shown that
CvaB, together with CvaA and TolC proteins, directs the secretion
of the colicin V with the cleavage of a double-glycine leader
peptide [1,2,3]. Sequence alignments indicate that CvaB protein
belongs to the ABC superfamily [2]. It is predicted to span the
membrane six times and contains an ATP-binding site in its C-
terminal cytoplasmic domain [2,4]. The amino acid sequence of
this ATP-binding domain is highly conserved among many
proteins involved in export processes, including the mammalian
MDR family of drug exporters [5,6] and CFTR, the chloride
channel defective in patients with cystic fibrosis [7,8]. For the
export of bacteriocin precursors containing a short leader peptides
of the double-glycine type, such as colicin V, it has been proposed
that the substrate-binding site in the proteolytic domain binds a
bacteriocin precursor, and hydrolysis of ATP molecule(s) induces a
conformational change in the ABC transporter that results in the
simultaneous cleavage and translocation of the peptide [9]. Point
mutations in the CvaB N-terminal putative protease domain and
C-terminal nucleotide-binding motif severely affect colicin V
secretion, suggesting that these two domains are critical for CvaB
function [4,10].
Previous work [10] has shown that the N-terminal domain of
CvaB (BntD) possesses Ca
2+-dependent cysteine proteolytic
activity. Mutations on critical residues Cys32 and His105 totally
abolish its proteolytic activity and colicin V secretion, indicating
that the BntD is indeed important in colicin V precursor
processing. Based on protein sequence analysis, the BntD belongs
to the C39 peptidase superfamily, which contains the Cys-His-Asp
sequence as a catalytic triad. Furthermore, Dessens et al. [11]
reported that Asp forms hydrogen bonds with His to help orient
the imidazole ring of the His to lie in a favorable position to
interact with the Cys. In this work sequence alignment and site-
directed mutagenesis indicate that Asp121 forms part of the
catalytic triad and is important for colicin V secretion. Molecular
modeling and sequence alignment of the N-terminal domain of
CvaB have been used to predict its 3-D protein structure and
locate potentially important residues in the vicinity of active sites of
this cysteine protease. Pro122, Gln26, Trp101, Asp102, Val108,
Leu76, and Gly77 in the neighborhood of the critical Cys32,
His105 and Asp121 are shown to be functionally important in the
secretion of a biologically active colicin V.
Results
Identification of Asp121 as the third residue in the CvaB
proteolytic catalytic triad
Previous studies [10] showed that Cys32 and His105 are critical
residues for cysteine proteolytic activity of the N-terminal domain
of CvaB and for colicin V secretion activity. We therefore searched
for the third residue of the catalytic triad. It has been suggested
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working along with the Cys and His residues to give proteolytic
activity [11]. It has also been suggested that either Asn or Asp are
involved in hydrogen bonding with the requisite, active site His
residue to stabilize the thiolate-imidazolium ion pair [12,13]. The
molecular modeling of N-terminal of CvaB (BntD) showed that
Asn70 and Asn115 are the only two Asn residues close to His105
(Fig. 1A), though neither lies within the conserved region
comparable to the C39 protease family sequence alignment
(Fig. 2). Nevertheless, site-directed mutagenesis on these two
residues changing them with Gln and Lys, respectively were
carried out. The mutations, however, did not affect colicin V
secretion (Table 1), indicating that neither Asn70 nor Asn115 is
involved in the catalytic triad of proteolytic activity or secretion.
According to sequence alignment of the catalytic triad (Fig. 2),
Asp121 could be the third conserved residue of N-terminal CvaB
and be involved in catalytic triad formation. Accordingly, this
residue was modified using site-directed mutagenesis. Replace-
ments of Asp121 with Ala, Ser and Asn lost all colicin V secretion
activity (Table 1). All the mutants were tested at 30uC, 37uC, and
42uC, and none of them showed secretion activity, indicating that
Asp121 is indeed essential for colicin V secretion activity.
Surprisingly, mutant D121E showed partial secretion activity
(about 25%) at 30uC and 37uC, but not 42uC, indicating that the
carboxyl group of Asp might be important for colicin V secretion.
The importance of Asp121/Pro122 for proteolytic activity
Pro122 is a conserved residue in the N-terminal CvaB
neighboring, as it does, Asp121. Mutations of Pro122, including
changing it to an Ala (P122A) and a Ser (P122S) resulted in
defective colicin V secretion at 30uC, 37uC, or 42uC (Table 1).
Based on the 3D model prediction (Fig. 1A), Pro122 residue is
located at the alpha-helix turn that may be important for the
maintenance of the helix structure. Consequently we mutated the
Pro122 further, changing it into Gly, Phe, and Val; no colicin V
activity was found (Table 1). The reversal of both residues, in a
double mutation of D122P/P122D, also resulted in the loss of any
secretion activity (Table 1), showing the critical positions of these
two amino acids in the secretion of colicin V. These results
indicate that the residues Asp121/Pro122 and their alignments are
important for the secretion of active colicin V.
In order to determine whether the loss of colicin V secretion
activity is due to protein degradation, we examined the stability of
the mutated CvaB, as well as the stability of its partner CvaA.
Such analysis, using immunoblots demonstrated that the CvaB
and CvaA of Asp121 and Pro122 mutants are structurally stable
(Fig. 3A), indicating that the loss of secretion activity is not due to
the protein degradation of either CvaB or its associate protein,
Figure 1. Molecular modeling of CvaB N-terminal domain in
the vicinity of Cys32 and His105 residues. Coordinates of the
crystal structures of the E.coli translation inhibitor (PDB: 1JD1) and
photosynthesis metal transporter (PDB: 1G8P) were obtained from
protein database (www.rcsb.org/pdb) and used as homolog templates
for the molecular modeling. Amino acid residues 1 through 87 are
based on template 1G8P, and residues 88 through 125 are based on
template 1JD1. (A) The catalytic triad. Asn70 (7.68 A ˚), and Asn115
(14.9 A ˚) are the only two Asn residues close to His105. Asp121 (18.52 A ˚
to His105) is the third residue for the catalytic triad. Gln26 is 7.6 A ˚ to
Cys32. (B) Trp101, Asp102, and Val108 are close to His105 to form
potential H-bonds (4.15 A ˚ for Trp101, 3.2 A ˚ for Asp102 and 3.4 A ˚ for
Val108). Three residues, Leu76, Gly77, and Thr80, around Trp101 and
Asp102 are also shown. (C) The critical residue Cys32 is shown with the
surrounding residues, Gln26 (7.6 A ˚), Asp49 (3.83 A ˚), Tyr52 (3.4 A ˚), Lys56
(4.99 A ˚), and Ala67 (5.11 A ˚ ).
doi:10.1371/journal.pone.0035382.g001
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secretion in the CvaB mutants. The amounts of colicin V synthesis
in the cell were not affected in both wild type and mutants CvaB as
expected (data not shown). However, immunoblot analysis of
secreted colicinV indicated that the secretion was defective in the
CvaB mutants (Fig. 3A, lower panel). These data confirmed that
the loss of secretion activity of colicin V secretion is due to the
defect of the N-terminal CvaB. The N-terminal CvaB mutant
proteolytic domains, BntD-D121A and BntD-P122A, were cloned
and purified to determine their proteolytic activity. Using LA-pNA
as a substrate, the protease activity of both mutants was greatly
reduced as compared to wild-type (Fig. 3B), with little protease
activity being evident, even after 24 hours incubation. These data
indicate that Asp121 and Pro122 are both critical for N-terminal
CvaB protease activity and colicin V secretion.
Additional important residues surrounding His105
Based on sequence alignment and protein modeling, there are
several possible residues surrounding Asp121 which may also form
H-bond interactions with His105 imidazole ring including
Trp101, Asp102, Val108, Leu76 and Gly77. The mutations of
these residues were characterized for their involvement in colicin
V secretion activity.
Trp101
It has been reported that Trp is proximal to His and Cys in the
active site of Conidiobolus alkaline protease [14]. Molecular
modeling of N-terminal CvaB predicts that Trp101 is 4.15 A ˚
away from the active site His105. Replacement of Trp101 with
Phe and Tyr showed retention of 75% of wild-type colicin V
secretion activity, while 50% of colicin V activity was observed
when Trp101 was replaced with Ala or Ser. Replacement of
Trp101 with Asp (W101D) showed even less secretion activity
(only 25%). However, replacement with His, Pro, and Lys showed
no secretion activity at all (Table 2). These results strongly suggest
that Trp101 plays an important role in colicin V activity, and that
phenyl group of phenylalanine or tyrosine can effectively substitute
for the indole ring of Trp101, potentially stabilizing the His105
residue during the catalytic reaction.
Asp102
It has been suggested that an Asp residue is involved in
hydrogen bonding network to the catalytically critical His residue
in cysteine protease. In so doing, it is thought to stabilize the
active-site thiolate-imidazolium ion pair and enhance catalytic
activity [15,16]. Based on the molecular modeling prediction, the
oxygen atom of Asp102 in CvaB is 3.2 A ˚ away from the nitrogen
of the His105 imidazole ring. To determine whether Asp102 is
important in this function of N-terminal CvaB, colicin V activity
assays were performed in selected mutants. Replacement of
Asp102 with Lys, Tyr, Gly, Thr, Gln, Asn, and His showed
comparable secretion activity to wild-type (Table 2). Replacement
of Asp102 to Ser, Cys, and Glu showed 75% of wild-type colicin V
secretion activity, while Ala, Phe, and Pro replacements
completely abolished activity (Table 2). Moreover, double
mutations of W101D & D102W totally abolished secretion
activity, indicating that exchange of residues at position 101 and
102 cannot complement the amino acid property and the indole
Figure 2. Alignment of N-terminal CvaB (BntD) with the C39 peptidase family. Amino acid multiple sequence alignments were performed
using the ClustalW2 program. The sequences were taken from the Swiss Protein Database or the GenBank
TM/EBI Data Bank. Identical and similar
residues are marked with asterisks and dots, respectively. The three conserved catalytic triad residues are marked as dark gray color. The numbers on
the left and right refer to amino acid positions. The BntD is the N-terminal protease domain of CvaB (a.a. 1–171), ComA protein is a bacteriocin-
processing peptidase from Streptococcus pneumonia, Clyb protein is a mersacidin lantibiotic processing peptidase from Streptococcus pneumonia,
NukT is family C39 non-peptidase homologues from Staphylococcus warneri.
doi:10.1371/journal.pone.0035382.g002
Table 1. The Mutation of Conserved residues on colicin V
secretion.
Residue Mutations Activity
Asn70 N70G, N70K ++++
Asn115 N115G, N115K ++++
Asp121 D121A, D121S, D121N _
D121E +
Pro122 P122A, P122S, P122G, P122F, P122V _
Asp121/Pro122 D121P-P122D _
Mutation and enzymatic activity are defined as in Material and Methods.
doi:10.1371/journal.pone.0035382.t001
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mutagenesis results, hydrophilic residues appear to be required at
the position 102.
Phe103
Phe103 is another residue nearby Tyr101 which could also
provide a phenyl ring in close proximity to His105. Even so,
according to 3-D structure prediction, they are not considered to
be neighbors. Replacement of Phe103 to Tyr or Trp showed
100% secretion activity comparable to wild-type; moreover,
replacements to hydrophobic Ala, hydrophilic Ser, and charged
His, did not change colicin V secretion activity, indicating that
Phe103 is not important for CvaB function the secretion of active
colicin V (Data not shown).
Val108
According to the N-terminal CvaB molecular modeling, Val108
is 3.4 A ˚ away from His105 residue. Replacement of Val108 to Leu
(V108L) resulted in a slight reduction in the secretion activity (to
75%); replacement with Ser reduced activity further (to 50%);
while replacement to Ala reduced activity even further (to 25%).
Mutations of Val108 to charged residues Lys and Asp totally
abolished secretion activity (Table 2). Interestingly, when the
V108A mutation was combined with any other second mutation,
the colicin V secretion activity was totally abolished (data not
shown). These results indicate that Val108 is also important in the
secretion of active colicin V.
Trp101, Asp102, and Val108 mutants are structurally
stable
To determine whether the mutations that abolish secretion
activity are due to functional or structural defects, the stability of
CvaB, and its interacting partner, CvaA were determined. Flag-
epitope was inserted into the C-terminal of CvaB wild-type,
Trp101, and Asp102 mutants (SI Table 1) to detect CvaB; the
insertions of Flag-epitope have no effect on the secretion of active
colicin V. To determine whether the lost activity of several Trp101
mutants was due to functional defects or structural instability,
membrane protein preparations from these mutants were
electrophoresed on SDS-PAGE and subjected to immunoblot
analysis. The results showed that the mutated CvaBs are
structurally stable and can be detected immunologically the
otherwise inactive W101Y, W101K, W101P, and W101H
mutants as detected by Flag antibodies (Fig. 4A). Similar results
were obtained with Asp102 mutants D102F, D102A, D102P,
D102W&W101D, and D102K (Fig. 4B), suggesting that loss of
activity in functionally compromised Asp102 mutants was due to
functional defect.
Similarly, membrane proteins of V108A mutants were tested for
CvaA and CvaB stability through immunoblotting. The results
showed that CvaA (Fig. 4C) and CvaB proteins (Fig. 4D) of
V108L, V108S, V108A, V108K, and V108D mutants could all be
detected immunologically, indicating that secretion defect of these
mutants are not due to structural instability of the mutated CvaB.
We conclude that Trp101, Asp102 and Val108 are functionally
Figure 3. Protease stability and protein activity of Asp121 and
Pro122. (A) Membranes of wild-type and mutants were analyzed by
SDS-gel electrophoresis for immunoblots. The CvaB and CvaA were
detected by CvaB and CvaA antibodies. The secreted colicin V from
assay medium was precipitated by TCA and western blot with colicin V
peptide antibody. (B).Purified BntD proteins of wild-type and mutants
were incubated with LA-pNA with protease reaction buffer. The
absorbance at 405 nm was monitored at the time indicated.
doi:10.1371/journal.pone.0035382.g003
Table 2. Mutation of the residues around the His 105 on
colicin V secretion.
Residue Mutations Activity
Trp101 W101Y, W101F +++
W101A, W101S ++
W101D +
W101K, W101P, W101H 2
Asp102 D102K, D102G,D102Y, D102H, D102T, D102N, D102Q ++++
D102S, D102E, D102C +++
D102W +
D102A, D102F, D102P, 2
W101D -D102W 2
Val108 V108L +++
V108S ++
V108A +
V108K, V108D 2
Mutation and enzymatic activity are defined as in Material and Methods.
doi:10.1371/journal.pone.0035382.t002
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the critical residue, His105.
Important residues around Trp101 and Asp102
Molecular modeling showed that Leu76, Gly77, and Thr80
residues are around important residues Trp101 and Asp102
(Fig. 1B). Leu76 is 2.9 A ˚ to Asp102 and 3.1 A ˚ to Thr80. Gly77 is
3.7 A ˚ to Trp101, 4.3 A ˚ to Asp102, and 4.3 A ˚ to His105. Thr80 is
3.2 A ˚ to both Trp101 and Asp102. To determine whether these
three residues may be potentially involved in the secretion of active
colicin V, site-directed mutagenesis was performed. Replacement
of Gly77 for Ala or Ser reduced colicin V secretion activity by
50%; replacement of Gly77 to Pro totally abolished activity;
replacements of Leu76 to Ala, Ser, and Val reduced activity to
50% at 37uC while replacement of Thr80 to Ser had no effect.
Interestingly, replacements of Leu76 to Ala, Ser, or Val retained
most colicin V activity at 30uC, but not at 42uC (Table 3 and data
not shown). These results indicated that Leu76 and Gly77 are
temperature-sensitive mutations affecting colicin V secretion
activity.
Important residues surrounding Cys32: involvement of
Gln26
Previous studies showed that Cys32 is also critical for both
colicin V secretion activity and cysteine proteolytic activity of N-
terminal CvaB (BntD) [10]. Furthermore sequence alignment
shows that Gln26, corresponding to Gln19 in papain, is conserved
among the cysteine proteases. It has been proposed that Gln19 in
papain forms an ‘‘oxyanion hole’’ with Cys25, and that this, in
turn, stabilizes the Cys- and His- ion pair structure of calcium-free
human m-calpain. 3-D structural analysis of papain also shows
that the oxygen atom of Gln99, also conserved among cysteine
protease [15,17,18], is at a distance of 7.73 A ˚ from the sulfur of
the critical Cys105 residue (PDB:1KFU) [19]. 3-D modeling of
BntD along with sequence alignment predicts that the oxygen of
Gln26 also lies at a distance of 7.6 A ˚ to the sulfur of Cys32,
suggesting that Gln26 might be the amino acid involved in
cysteine proteolytic activity of N-terminal CvaB (Fig. 1C and
Fig. 2).
Site-directed mutagenesis was performed to determine whether
Gln26 is involved in colicin V secretion activity. Replacement of
Gln26 to Ala and Asn (Q26A and Q26N, respectively) had only
minimal effect on colicin V secretion; while replacements of Gln26
for charged residues Lys, Glu, and His completely abolished
colicin V secretion at 37uC (Table 4). However, replacement of
Gln26 to Glu (Q26E) only reduced colicin V secretion by 50% at
30uC. These results showed that the Gln26 residue is involved in
colicin V secretion activity.
Molecular modeling also indicated that four residues, Asp49,
Tyr52, Lys56, and Ala67, are in the vicinity of critical residue
Cys32 at a distance of 3.83 A ˚, 3.4 A ˚, 4.99 A ˚, and 5.11 A ˚,
respectively (Fig. 1C) [12,13,17,20]. Site-directed mutagenesis on
Ala67, Lys56, and Tyr52 residues did not affect colicin V secretion
activity (data not shown). However, replacements of Asp49 to Glu
and Ser reduced secretion activity to 75%; while replacements of
Asp49 for Lys and Ala reduced activity to 50% -indicating that
hydrophilic and acidic residues might also play some role in the
secretion mechanism.
Figure 4. Stability of CvaA and CvaB in the membranes of
Trp101, Asp102, and Val108 mutants. Wild-type and mutants cvaB
plasmids were co-transformed with pHK11-4 plasmid lacking cvaB and
incubated at 37uC. (A) Trp101 mutants CvaBs were detected by Flag
antibodies. Lane 1, wild-type; 2, W101Y; 3, W101K; 4, W101P; 5, W101H
mutants. (B) Asp102 mutant CvaBs were detected by Flag antibodies.
Lane1, wild-type; lane 2, D102F; lane 3, D102A; lane 4, D102P; lane 5,
D102W & W101D; lane 6, D102K mutants. Val108 mutant membranes
were detected with CvaA antibodies (C) or by N-terminal domain of
CvaB antibodies (D). Lane 1, wild-type; lane 2, V108L; lane 3, V108S; lane
4, V108A; lane 5, V108K; lane 6, V108D; lane 7, pHK11-4. The samples of
membrane proteins were run on 10% SDS-PAGE and subjected to
immunoblotting as described in Materials & Methods.
doi:10.1371/journal.pone.0035382.g004
Table 3. Colicin V secretion activity on the conserved residue,
Leu76, Gly77 and Tyr80.
Mutations 376C4 2 6C
CvaB WT ++++ ++++
L76A ++ 2
L76S ++ 2
L76V ++ +
G77A, G77S ++ ++
G77P 22
T80S ++++ ++++
Mutation and enzymatic activity are defined as in Material and Methods.
doi:10.1371/journal.pone.0035382.t003
Table 4. Direct colony assay for Gln26 site-directed mutants.
Mutation 306C3 7 6C
CvaB WT +++++ +++++
Q26A ++++ ++++
Q26N ++++ ++++
Q26E ++ +
Q26K +/2 +
Q26H +/2 +
Mutation and enzymatic activity are defined as in Material and Methods.
doi:10.1371/journal.pone.0035382.t004
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Previous study identified Cys32 and His105 of N-ternal CvaB
(BntD) as being two of the three residues that are critical for both
colicin V secretion activity as well as its cysteine proteolytic activity
[10]. Most cysteine proteases contain Cys-His-Asn as their
catalytic triad. However, it has has been reported that Asp, can
replace Asn as the third residue, necessary to form the critical
hydrogen bond with the imidazole ring of the histidine in order to
stabilize its interaction with the cysteine residue, and thus
contribute to the structural integrity of the active site
[12,13,17,20]. Molecular modeling of BntD shows that Asn70,
lying at a distance of 7.68 A ˚ form His105, and Asn115, at a
distance of 14.9 A ˚, are the only two Asn residues that are
potentially close enough to the critical histidine residue to have any
interaction. Even so, these distances would not be close enough to
form H-bonds. There is, however a conserved aspartate residue
(Asp121) which through sequence alignment could be a candidate
for the third position in the catalytic triad [21]. The directed
replacement of this aspartate residue for either alanine or
asparagine (D121A and D121N, respectively) results in a
completely defective colicin V. Replacement of Asp121 with the
common third catalytic residue Asn in cysteine protease, however,
failed to restore the colicin V secretion activity, which suggests a
role of the carboxyl side chain of the aspartate residue in colicin V
secretion. Although Asp cannot be considered an essential catalytic
residue in the cysteine protease [22,23,24], surprisingly, the
mutant D121E protein loses most of its protease activity and is
temperature-sensitive for secretion of active colicin V, indicating
that Asp121 is functionally important in the protease activity of
CvaB. In the D121N mutation, the change of an OH group for an
NH2 group eliminates the negative charge in the van der Waals
surface of the side chain atoms. Thus, it has been suggested that
the carboxyl group on the Asp would be important for the catalytic
activity across different pH ranges [25], with the protease activity
of D121N being more active in a high pH environment [26].
Moreover, replacement of Asp with Glu (D121E) partially retains
the colicin V secretion activity, suggesting that the carboxyl group
is indeed important for the colicin V secretion. It was reported that
Trp- Phe- and Pro- of cysteine protease stack together to help
forming and stabilizing the catalytic triad [27]. Based on the 3D
modeling, the Pro 122 locates on the end of helix structure next to
Asp121. All the mutations of Pro122 lose colicin V secretion
activity. Thus, these mutations may change the interaction with
Trp and Phe to destabilize the catalytic triad. Interestingly, the
reversal of the two residues, D121P/P122D, result in loss of
activity, indicating the importance of amino acid residues
alignments.
For cysteine protease, it has been suggested that the hydrogen
bond between the side chain of His and Asn is buried in a
hydrophobic region composed mainly of the side chains of residues
Phe and Trp [28]. Moreover, a Trp indole ring interacts with a
protonated His imidazole ring to increase the pKa and stability of
His [14,28]. The Trp-His interaction shields the hydrogen bond of
His-Asn from external solvent to facilitate different steps in the
catalytic mechanism of the enzyme [12]. Previous studies indicated
that Trp is essential for the active site of an alkaline serine protease
[14], and that the imidazole ring is essential for the proteolysis
[29]. Since Asn is not involved in colicin V secretion, Trp101 is the
only Trp residue that could potentially interact with His105 in this
way. Site-directed mutagenesis of Trp101 showed that Trp-to-Phe
and Trp-to-Tyr substitutions can be tolerated for activity, but five-
carbon ring His and Pro substitutions cannot. Thus, this His-Trp
interaction in colicin V system is probably important for the
Cys-His ion pair stability and the catalytic activity through the
effects of increasing the pKa of His.
The molecular modeling predicts the charged Asp102 may
interact with the nitrogen of the imidazole ring in His105 in the
distance of 3.24 A ˚ to form a hydrogen-bonding network.
Replacements of Asp102 with hydrophobic residues, such as
Ala, Trp, and Phe, totally abolish colicin V secretion activity. On
the other hand hydrophilic residue replacements retain 75,100%
of wild-type activity, suggesting that hydrophilic residues are
important in hydrogen-bonding network in this position. Menard
et al., [15,16] reported that Asp158 in papain is in proximity to
active site His and is involved in stabilizing the thiolate-
imidazolium ion pair by hydrogen-bonding interactions. However,
the charge and the hydrogen bonds of Asp158 in papain both
contribute to the activity of the enzyme. The molecular modeling
of BntD showed that Leu76, Gly77, and Thr80 are in the close
distance to Trp101 and Asp102. Replacement of Leu76 to Ala,
Ser, and Val reduced colicin V activity at 37uC, but totally
abolished the activity at 42uC, indicating that Leu76 is involved in
interaction result in temperature-sensitivity. Site-directed muta-
genesis on Gly77 to Ala and Ser showed 50% colicin V activity,
but G77P lost all activity, suggesting that Gly77 residue is involved
in secretion activity but is not involved in turning the structure.
Several residues surrounding critical residue Cys32 were tested
and only Gln26 affected colicin V secretion activity. Sequence
alignment shows that Gln26 corresponding to Gln19 in papain is
conserved among cysteine proteases. Gln19 is reported to form an
‘‘oxyanion hole’’ with Cys25 that stabilizes the Cys-His ion pair. In
colicin V system, Gln26 mutants show reduced colicin V activity.
This work identifies Asp as the third residue of catalytic triad of
His-Cys-Asp, and shows that additional surrounding residues and
their sequence alignments contribute to the cysteine protease
activity and the secretion of active colicin V.
Materials and Methods
Media and growth conditions
TB (10 g of tryptone and 8 g of NaCl per liter) was used as both
liquid and solid (with 1.5% agar) growth media for transformation.
TB plates with 0.7% agar as semi- solid growth media for lawn
were used for colicin V secretion assay [2,30]. Ampicillin and
chloramphenicol were used at final concentrations of 100 mg/ml
and 30 mg/ml, respectively.
Bacterial strains, plasmids and reagents
The strains and plasmids used in this study are listed in Table
S1. Escherichia coli DH5a was used as the bacterial hosts. E. coli
colicin V sensitive strain 71–18 for colicin V halo activity assay
[2,30], and colicin plasmids were obtained from Dr. R. Kolter
(Harvard Medical School, Boston, MA). Plasmid pHK11-4
contains intact cvaA and cvaC but not cvaB. For colicin V secretion
assays, cvaB and its mutations were provided by a complementary
plasmid pACYC184. Recombinant DNA manipulations were
performed essentially as described by Sambrook et al [31]. The
expression vector pTrcHis2B with His6-tag at C-terminus was
from Invitrogen (Carlsbad, CA).
Site-directed mutagenesis
All mutagenesis were carried out by PCR using oligonucleotides
containing the desired mutations. The standard PCR reaction in a
total volume of 50 ml contained 20 ng of linearized plasmid
template, 400 ng of each oligonucleotide primers, 200 mM of each
deoxynucleotide triphosphate, and 5 units of Ex Taq DNA
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provided by the manufacturer.
To generate the desired site-directed mutagenesis constructs, a
three-round asymmetric PCR strategy was used as previously
described [10,32]. All mutations were confirmed by sequencing
using an ABI Prism Big Dye Terminator Cycle Sequencing Ready
Reaction Kit (Applied Biosystems, Foster City, CA) and
appropriate primers.
Protein sequence alignment and dynamic protein
modeling
The N-terminal CvaB (BntD, amino acids 1–171) has previous
determined as the protease domain [10]. The BntD protein
sequence was aligned with other C39 peptidase family by using the
ClustalW2 multiple sequence alignment (http://www.ebi.ac.uk/
Tools/msa/clustalw2/) [33].
Coordinates of the crystal structures of the E. coli translation
inhibitor (PDB: 1JD1) and photosynthesis metal transporter (PDB:
1G8P) were obtained from protein database (www.rcsb.org/pdb)
and used as templates for the molecular modeling. The BntD
sequence was aligned with the templates using BLAST (www.ncbi.
nlm.nih.gov/BLAST) and FASTA (www.ebi.ac.uk/fasta33). The
corresponding residues of CvaB were graphically incorporated
into the published crystallographic coordinates of templates using
program AMMP (http://www.cs.gsu.edu/,cscrwh), creating the
structure for the dynamic modeling computations. The computa-
tions, including energy minimization and molecular dynamics,
generate minimized structure, which is displayed using RasMol
molecular display program (http://www.bernstein-plus-sons.com/
software/rasmol).
Colicin V activity assay
Direct colony halo assays were performed as described in
Skvirsky et al. [30] with modifications [10]. DH5a cells containing
various plasmids grown overnight in TB broth were spotted on
colicin V sensitive 71-18-overlaid TB plates and incubated at
30uC, 37uC, or 42uC. All the results were shown as 37uC unless
otherwise indicated. The halo area around colony was measured
overnight or at different time as indicated during incubation.
Amino acids are shown in the one-letter code. The description of
the mutations represented the amino acid change. Letters before
the number indicates the original amino acid residues, and the
letter after the number indicates the introduced amino acid
residues. The symbol represented colicin V secretion activity:
Wild-type (++++) is used as 100% secretion activity. (++) is used as
approximate 50% secretion activity compared to the wild type, + is
used as 25%. Symbol ‘‘2’’ indicates no secretion activity.
Protein Purification and Protease activity assay
N-terminal CvaB (BntD) was cloned, expressed, purified and
used for proteolytic assay as previous described [10]. The reaction
mixtures contained 4.32 mg purified BntD with protease reaction
buffer containing 50 mM Tris-HCl, pH 7.6, 5 mM CaCl2,
10 mM 2-mercaptoethanol, and 5 mM dithiothreitol and were
first incubated at 37uC for 10 mins. The substrate, L-arginine p-
nitroanilide (LA-pNA) was added into the mixture with a final
concentration of 1 mM. The cleavage product, p-nitroaniline, was
monitored at various times in a Bio-Rad spectrophotometer at
O.D. 405 nm. Background of hydrolysis of the substrate without
BntD was subtracted.
Membrane preparations and Western immunoblots
DH5a cells containing appropriate plasmids grown overnight in
TB at the presence of appropriate antibiotics at 30uC were diluted
to an OD600 of ,0.1 and incubated for growth. When OD600
reached ,0.5, the cells were spun down and washed once by TB,
and the cells were re-suspended in TB, induced with 0.5 mM 2,29-
dipyridyl, and harvested 2 hr later. Cells were suspended in
50 mM Tris - HCl (pH 8.0) - 50 mM NaCl - 20% glycerol plus
Complete Protease Inhibitor Cocktail (Roche, IN) and 1 mM N-
ethylmaleimide (NEM), and lysed with a French Press as described
[10]. Lysates were centrifuged for 8 min at 4,0006g to remove cell
debris, and the supernatants were centrifuged at 100,000 rpm for
20 min at 4uC in a Beckman TLA100.3 rotor. The pellet fractions
containing total membranes were suspended in sample buffer
containing 1 mM NEM, complete protease inhibitor cocktail, and
4% SDS. For detection of CvaB and CvaA, membranes were
incubated at 37uC for 30 min prior subjecting to 10% SDS-
PAGE. For Western immunoblottings, alkaline phosphate-conju-
gated goat anti-rabbit immunoglobulin G (Bio-Rad Laboratories,
Hercules, CA) was used as the secondary antibody for anti-CvaA
[34], anti-N-terminal CvaB and anti-colicin V antibody [10];
alkaline phosphate-conjugated goat anti-mouse immunoglobulin
G (Promega, Madison, WI) was used as the secondary antibodies
for anti-Flag antibodies which was obtained from Sigma (St. Louis,
MO).
Supporting Information
Table S1 Bacterial strains and plasmids. The strains and
plasmids used in this study are listed. The details are defined as in
Material and Methods.
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